Attached files
file | filename |
---|---|
EX-32.2 - CERTIFICATION - BIOPHARM ASIA, INC. | ex32-2.htm |
EX-31.2 - CERTIFICATION - BIOPHARM ASIA, INC. | ex31-2.htm |
EX-31.1 - CERTIFICATION - BIOPHARM ASIA, INC. | ex31-1.htm |
10-Q/A - AMENDMENT TO QUARTERLY REPORT - BIOPHARM ASIA, INC. | biopharm_10qa1-063009.htm |
EXHIBIT
32.1
SECTION
1350 CERTIFICATION
In
connection with the Quarterly Report of BioPharm Asia, Inc..
(the "Company") on Form 10-Q/A for the quarter ended June 30, 2009, as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, Yunlu Yin, President and Chief Executive Officer of the Company,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
(1) The
Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and
(2) The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of
the Company.
BioPharm
Asia, Inc.
|
|||
Dated:
October 8, 2009
|
By:
|
/s/ Yunlu
Yin
|
|
Yunlu
Yin
President
and Chief Executive Officer
|